SPAG9 and prostate cancer: Similarly, miR-200a can promote apoptosis in prostate cancer cells through BRD4/AR signaling pathway (234), by directly targeting SIRT1 (236) or by targeting Sperm-associated antigen 9 (SPAG9) (100).